(Q43818088)

English

Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

immunosuppression

1 reference

based on heuristic

inferred from title

Swiss HIV Cohort Study

12

object named as

Swiss HIV Cohort Study

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Manuel Battegay

1

object named as

M Battegay

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

P L Vernazza

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Bernasconi

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Flepp

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Sendi

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Erb

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R Malinverni

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C Jaccard

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Morgenthaler

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

V Bedoucha

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

B Hirschel

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

35-42

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

HIV phenotype switching during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Safety and activity of saquinavir in HIV infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Correlation of response to treatment and HIV genotypic changes during phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with 500 × 106/l CD4 cells treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00047.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2001.00047.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43818088&oldid=2103618777"